BC Cancer has a duty to act on behalf of our patients and the general public to ensure that a culture of accountability is fostered
The US National Institutes of Health (NIH) financial conflict of interest (FCOI) regulations require all Investigators to disclose any significant financial interest to their institution. Before a Subrecipient Investigator is listed on a NIH proposal or a sub-award will be issued, BC Cancer will be asking Subrecipient Investigators:
- What institutional/university policy they are following, and
- If they have any FCOIs to report.
Follow the steps below to find out what you have to do as a Subrecipient Investigator on a BC Cancer NIH proposal/project.
If Subrecipient Institution is listed as having a NIH compliant policy then no further action is required.
BC Cancer is listed on the
FDP Clearinghouse of Compliant Institutions and Entities under the institutional title "British Columbia Cancer Agency Branch (BC Cancer Agency)".
If Subrecipient Institution is not on FDP Clearinghouse then the Subrecipient Investigator will need to have this form completed and submitted to
BCCACOI@phsa.ca before the proposal will be submitted.
1If Subrecipient Investigator is following Subrecipient Institution policy
The Subrecipient Institution must complete the
Subrecipient Investigator - FCOI Disclosure & Management Plan when there is a FCOI to report and annually thereafter.
2If Subrecipient Investigator is following BC Cancer/PHSA's policy
On an annual basis, the Subrecipient Investigator must complete the
Subrecipient Investigator - FCOI Declaration
The procedures detailed here are conditions of receiving funding. BC Cancer reserves the right to discontinue funding if a Subrecipient Investigator fails to comply.